The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
Open accessAbstract
Vero cell heparin-binding epidermal growth factor-like growth factor (HB-EGF) is synthesized as a 20- to 30-kDa membrane-anchored HB-EGF precursor (proHB-EGF). Localization and processing of proHB-EGF, both constitutive and 12-O-tetradecanoylphorbol 13-acetate (TPA)-inducible, was examined in Vero cells overexpressing recombinant HB-EGF (Vero H cells). Flow cytometry and fluorescence immunostaining demonstrated that Vero cell proHB-EGF is cell surface-associated and localized at the interface of cell to cell contact. Cell surface biotinylation and immunoprecipitation detected a 20- to 30-kDa heterogeneous proHB-EGF species. Vero H cell surface proHB-EGF turned over constitutively with a half-life of 1.5 h. Some of the 20- to 30-kDa cell surface-associated proHB-EGF was processed and a 14-kDa species of bioactive HB-EGF was released slowly, but most of the proHB-EGF was internalized, displaying a diffuse immunofluorescent staining pattern and accumulation of proHB-EGF in endosomes. Addition of TPA induced a rapid processing of proHB-EGF at a Pro148-Val149 site with a half-life of 7min. The TPA effect was abrogated by the protein kinase C inhibitors, staurosporine and H7. Kinetic analysis showed that loss of cell surface proHB-EGF is maximal at 30 min after addition of TPA and that proHB-EGF is resynthesized and the initial cell surface levels are regained within 12-24 h. Loss of cell surface proHB-EGF was concomitant with appearance of 14- and 19-kDa soluble HB-EGF species in conditioned medium. Vero H cell-associated proHB-EGF is a juxtacrine growth factor for EP170.7 cells in coculture. Processing of proHB-EGF resulted in loss of juxtacrine activity and a simultaneous increase in soluble HB-EGF paracrine mitogenic activity. It was concluded that processing regulates HB-EGF bioactivity by converting it from a cell-surface juxtacrine growth factor to a processed, released soluble paracrine growth factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., & Klagsbrun, M. (1991) · Science · doi:10.1126/science.1840698 · Cited by 1,127
Self-citationChen, C. A., & Okayama, H. (1988) · PubMed · Cited by 894
Human transforming growth factor-α: Precursor structure and expression in E. coli
Derynck, R., Roberts, A. B., Winkler, M. E., Chen, E. Y., & Goeddel, D. V. (1984) · Cell · doi:10.1016/0092-8674(84)90550-6 · Cited by 877
MEMBRANE-ANCHORED GROWTH FACTORS
Massagué, J., & Pandiella, A. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002503 · Cited by 660
Moscatelli, D. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041310118 · Cited by 646
Das, S. K., Wang, X.-N., Paria, B. C., Damm, D., Abraham, J. A., Klagsbrun, M., Andrews, G. K., & Dey, S. K. (1994) · Development · doi:10.1242/dev.120.5.1071 · Cited by 569
Self-citationNaglich, J. G., Metherall, J. E., Russell, D. W., & Eidels, L. (1992) · Cell · doi:10.1016/0092-8674(92)90623-k · Cited by 551
Flanagan, J. G., Chan, D. C., & Leder, P. (1991) · Cell · doi:10.1016/0092-8674(91)90326-t · Cited by 550
Cloning and sequence analysis of a cDNA for rat transforming growth factor-α
Lee, D. C., Rose, T. M., Webb, N. R., & Todaro, G. J. (1985) · Nature · doi:10.1038/313489a0 · Cited by 381
Higashiyama, S., Abraham, J., & Klagsbrun, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.4.933 · Cited by 362
Self-citationHigashiyama, S., Lau, K., Besner, G. E., Abraham, J. A., & Klagsbrun, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42682-8 · Cited by 349
Self-citationAppearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.
Marikovsky, M., Breuing, K., Liu, P. Y., Eriksson, E., Higashiyama, S., Farber, P., Abraham, J., & Klagsbrun, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3889 · Cited by 325
Self-citationHuang, E. J., Nocka, K. H., Buck, J., & Besmer, P. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.3.349 · Cited by 316
Mitamura, T., Higashiyama, S., Taniguchi, N., Klagsbrun, M., & Mekada, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1015 · Cited by 306
Self-citationHigashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M., & Mekada, E. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.5.929 · Cited by 292
Self-citationIwamoto, R., Higashiyama, S., Mitamura, T., Taniguchi, N., Klagsbrun, M., & Mekada, E. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06516.x · Cited by 265
Self-citationHashimoto, K., Higashiyama, S., Asada, H., Hashimura, E., Kobayashi, T., Sudo, K., Nakagawa, T., Damm, D., Yoshikawa, K., & Taniguchi, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32127-0 · Cited by 228
Self-citationSignal Transduction Through the EGF Receptor Transfected in IL-3-Dependent Hematopoietic Cells
Pierce, J. H., Ruggiero, M., Fleming, T. P., Di Fiore, P. P., Greenberger, J. S., Varticovski, L., Schlessinger, J., Rovera, G., & Aaronson, S. A. (1988) · Science · doi:10.1126/science.3257584 · Cited by 226
Kerbiriou, D., & Griffin, J. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86421-9 · Cited by 223
Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process.
Pandiella, A., & Massagué, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1726 · Cited by 215
Kahn, J., Ingraham, R. H., Shirley, F., Migaki, G. I., & Kishimoto, T. K. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.2.461 · Cited by 196
Isolation and characterization of a macrophage-derived heparin-binding growth factor.
Besner, G., Higashiyama, S., & Klagsbrun, M. (1990) · Cell Regulation · doi:10.1091/mbc.1.11.811 · Cited by 186
Self-citationMiyagawa, J., Higashiyama, S., Kawata, S., Inui, Y., Tamura, S., Yamamoto, K., Nishida, M., Nakamura, T., Yamashita, S., & Matsuzawa, Y. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117669 · Cited by 165
Self-citationThompson, S. A., Higashiyama, S., Wood, K. M., Pollitt, N. S., Damm, D. L., McEnroe, G. A., Garrick, B. L., Ashton, N. M., Lau, K., & Hancock, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41979-x · Cited by 156
Self-citationUmata, T., Moriyama, Y., Futai, M., & Mekada, E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45829-2 · Cited by 156
Self-citationYOSHIZUMI, M., Kourembanas, S., Temizer, D. H., Cambria, R. P., Quertermous, T., & Lee, M. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50112-0 · Cited by 140
Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor.
Pandiella, A., & Massagué, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67662-3 · Cited by 130
Dluz, S., Higashiyama, S., Damm, D. L., Abraham, J. A., & Klagsbrun, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46848-7 · Cited by 127
Self-citationTemizer, D. H., YOSHIZUMI, M., Perrella, M. A., Susanni, E. E., Quertermous, T., & Lee, M. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35847-2 · Cited by 100
Heparin-Binding EGF-like Growth-Factor Is a Potent Mitogen for Rat Hepatocytes
Ito, N., Kawata, S., Tamura, S., Kiso, S., Tsushima, H., Damm, D. L., Abraham, J. A., Higashiyama, S., Taniguchi, N., & Matsuzawa, Y. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1004 · Cited by 92
Self-citationActivated release of membrane-anchored TGF-alpha in the absence of cytosol
Bosenberg, M., Pandiella, A., & Massagué, J. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.1.95 · Cited by 70
Teixidó, J., Wong, S. T., Lee, D. C., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39341-x · Cited by 63
Binding properties of diphtheria toxin to cells are altered by mutation in the fragment A domain.
Mekada, E., & Uchida, T. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38999-8 · Cited by 58
Self-citationPurification and characterization of transmembrane forms of heparin-binding EGF-like growth factor.
no, M., Raab, G., Lau, K., Abraham, J. A., & Klagsbrun, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47425-x · Cited by 58
Self-citationStein, J. A., & Rettenmier, C. W. (1991) · PubMed · Cited by 38
Almond, B. D., & Eidels, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47066-4 · Cited by 29
Cited by
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Harris, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00105-2 · Cited by 776
Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-35 · Cited by 724
Self-citationPrenzel, N., Fischer, O. M., Streit, S., Hart, S., & Ullrich, A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080011 · Cited by 673
Izumi, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7260 · Cited by 521
Metadata
- Authors
- Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E., & Taniguchi, N.
- Venue
- Molecular Biology of the Cell
- Published
- 1995-08
- Volume
- 6
- Issue
- 8
- Pages
- 967-980
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2084339088
- Cited by
- 266
- References
- 38
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.